azurity.com 的前十大競爭對手

cheplapharm.com

Die CHEPLAPHARM Arzneimittel GmbH ist ein familiengeführtes Pharmaunternehmen mit Hauptsitz in Deutschland, das weltweit Markenprodukte vertreibt.

jelmyto.com

JELMYTO is the first and only FDA-approved treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients

braftovi.pfizerpro.com

Explore uses, dosage & safety info for BRAFTOVI® (encorafenib), a combination treatment.

lillyoncologypipeline.com

explore our oncology pipeline database, discover promising therapies in development for diverse unmet medical needs, and download hcp resources

ojemdahcp.com

Learn about the disease and see the mechanism of action for OJEMDA. Please see Important Safety Information and full Prescribing Information.

truqaphcp.com

TRUQAP™ (capivasertib), a prescription medication in combination with fulvestrant that is targeted for patients with HR+/HER2- breast cancer with one or more PIK3CA/AKT1/PTEN -alteration.

isturisa.com

The efficacy of ISTURISA® (osilodrostat) was evaluated in two Phase 3 studies. Explore data and clinical outcomes. See Important Safety Information and full Prescribing Information for ISTURISA.

lunsumio.com

Learn more about LUNSUMIO® (mosunetuzumab-axgb) or LUNSUMIO VELO™, a prescription medicine for people with follicular lymphoma whose cancer has come back or did not respond to previous treatment, and who have already received two or more treatments for their cancer. See important safety including SERIOUS SIDE EFFECTS for more information.